| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |